Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2017-10-25
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Compare Between APRV and Bipap Ventilation in ARDS Patients
NCT06755320
APRV/BIPAP With Spontaneous Breathing on Lung Protection
NCT02071277
Ventilation dIstribution and effeCt of posTural Lateralization On Traumatic Lung injuRY: a Physiological Study
NCT06196125
BIPAP in the Management of Acute Respiratory Distress Syndrome
NCT05483959
Effect of Two Modes of Mechanical Ventilation on Metabolic Demands and Respiratory Mechanics
NCT04205422
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Resting Energy Expenditure
* Oxygenation
* Stability of Physiological Status as cardiovascular activity
* cardiac output
* arterial blood gas measurement including \[ blood PH, arterial oxygen tension, arterial carbon dioxide tension, bicarbonate level and base deficit\]
* lung and chest compliance
* Length of intensive care unit stay.
* The ICU mortality rate.
* The development of major complications as nosocomial infection (hospital acquired pneumonia and ventilator associated pneumonia), major atelectasis and pneumothorax.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Biphasic Intermittent Positive Airway Pressure (BIPAP) group:
Following endotracheal intubation BIPAP mode will be started with:
* Inspiratory positive airway pressure \[IPAP\] at 20 cmH2O
* Expiratory positive airway pressure \[EPAP\] at 5 cmH2O
* PRESSURE SUPPORT is difference between these two pressures \[IPAP\]- \[EPAP\]
* Mandatory pressure will be delivered at rate of 10-12/min. To produce an end tidal carbon dioxide partial pressure in the range of 35-40 mmHg hypercapnia will not be allowed
Biphasic Intermittent Positive Airway Pressure (BIPAP)
Following endotracheal intubation BIPAP mode will be started with:
* Inspiratory positive airway pressure \[IPAP\] at 20 cmH2O
* Expiratory positive airway pressure \[EPAP\] at 5 cmH2O
* PRESSURE SUPPORT is difference between these two pressures \[IPAP\]- \[EPAP\]
* Mandatory pressure will be delivered at rate of 10-12/min. To produce an end tidal carbon dioxide partial pressure in the range of 35-40 mmHg hypercapnia will not be allowed
Group 2
Airway Pressure Release Ventilation (APRV) group:
* high airway pressure (Phigh) will be set at 20 cmH2O
* low airway pressure ( Plow) will be set at 5 cmH2O
* the release phase setting will be adjusted to terminate the peak expiratory flow rate to ≥ 50%; release frequency of 10-12 cycles/min
* T high at 4.5-6 seconds
* T low at 0.5 to 0.8 second
Airway Pressure Release Ventilation (APRV)
* high airway pressure (Phigh) will be set at 20 cmH2O
* low airway pressure ( Plow) will be set at 5 cmH2O
* the release phase setting will be adjusted to terminate the peak expiratory flow rate to ≥ 50%; release frequency of 10-12 cycles/min
* T high at 4.5-6 seconds
* T low at 0.5 to 0.8 second
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biphasic Intermittent Positive Airway Pressure (BIPAP)
Following endotracheal intubation BIPAP mode will be started with:
* Inspiratory positive airway pressure \[IPAP\] at 20 cmH2O
* Expiratory positive airway pressure \[EPAP\] at 5 cmH2O
* PRESSURE SUPPORT is difference between these two pressures \[IPAP\]- \[EPAP\]
* Mandatory pressure will be delivered at rate of 10-12/min. To produce an end tidal carbon dioxide partial pressure in the range of 35-40 mmHg hypercapnia will not be allowed
Airway Pressure Release Ventilation (APRV)
* high airway pressure (Phigh) will be set at 20 cmH2O
* low airway pressure ( Plow) will be set at 5 cmH2O
* the release phase setting will be adjusted to terminate the peak expiratory flow rate to ≥ 50%; release frequency of 10-12 cycles/min
* T high at 4.5-6 seconds
* T low at 0.5 to 0.8 second
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant patient.
* Patient who will require fraction of inspired oxygen more than 0.6.
* Air leak from the chest tube.
* Patient with body temperature \> 39 Celsius.
* Acute hepatitis or severe liver disease (Child-Pugh class C).
* Left ventricular ejection fraction less than 30%.
* Heart rate less than 50 beats/min.
* Second or third-degree heart block.
* Systolic pressure \< 90 mmHg despite of infusion of 2 vasopressors.
* Patients with known endocrine dysfunction.
* Patient with hypothermia
* Patient on Positive end expiratory pressure more than 14 cmH2o
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sayed Kaoud Abd-Elshafy
Associate Professor of Anesthesiology and Critical Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB0000879659
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.